Clinical Trials Logo
  1. Home
  2. Partial Seizures
  3. NCT03340064

A Study of Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age — PEACH  

Partial Seizures Clinical Trial

Official title:
An Open-Label, Single-Arm, Multicenter Study of Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age

Clinical Trial Summary

This is a study to confirm the efficacy of levetiracetam as adjunctive treatment or as monotherapy in pediatric epilepsy subjects aged 1 month to less than 4 years of age with partial seizures.

Clinical Trial Description

The study will consist of 2 periods. The First Period (6 weeks drug treatment) is designed to confirm efficacy of levetiracetam (LEV), and the Second Period is designed to evaluate the long-term efficacy and safety of LEV. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03340064
Study type Interventional
Source UCB Pharma
Contact
Status Completed
Phase Phase 3
Start date November 30, 2017
Completion date July 28, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT01954121 - Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures Phase 3
Completed NCT01630057 - Evaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic Drug Phase 4
Completed NCT00327717 - Evaluating the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures Phase 3
Completed NCT00537238 - Pregabalin Versus Levetiracetam In Partial Seizures Phase 3
Completed NCT00141258 - Pregabalin Epilepsy Add-On Trial Phase 3
Terminated NCT00407797 - Pregabalin In Partial Seizures (PREPS): An Open-Label, Multicenter Add On Therapy Trial Phase 4
Completed NCT01136954 - A Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Extension Study) Phase 3
Completed NCT04257604 - A Study of Perampanel as Add-on Therapy in Adult and Adolescent Participants With Focal Seizures
Completed NCT01392768 - Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization Phase 3
Completed NCT01063764 - An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures Phase 3
Completed NCT00102713 - A Study for Treatment of Partial Seizures in Children Phase 3
Completed NCT01262677 - Once-A-Day Pregabalin For Partial Seizures Phase 3